Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-03-06

Clinical Trial Update: Thora-3Di™ Respiratory Rate Validation [NA]

View source ↗

Summary

A clinical trial update for Thora-3Di respiratory rate validation by Pneumacare Ltd; the study involves pulmonary disease and currently has an unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Thora-3Di

Snippet

Sponsor: Pneumacare Ltd | Conditions: Pulmonary Disease | NA | Status: UNKNOWN